1. Home
  2. BSRR vs PRTA Comparison

BSRR vs PRTA Comparison

Compare BSRR & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sierra Bancorp

BSRR

Sierra Bancorp

N/A

Current Price

$39.20

Market Cap

532.1M

Sector

Finance

ML Signal

N/A

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

N/A

Current Price

$8.54

Market Cap

458.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BSRR
PRTA
Founded
1977
2012
Country
United States
Ireland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
532.1M
458.4M
IPO Year
2001
2013

Fundamental Metrics

Financial Performance
Metric
BSRR
PRTA
Price
$39.20
$8.54
Analyst Decision
Hold
Hold
Analyst Count
5
6
Target Price
★ $43.00
$21.40
AVG Volume (30 Days)
31.0K
★ 337.4K
Earning Date
10-26-2026
11-05-2026
Dividend Yield
★ 2.77%
N/A
EPS Growth
★ 10.28
N/A
EPS
★ 1.72
0.26
Revenue
N/A
★ $814,000.00
Revenue This Year
$0.89
$758.69
Revenue Next Year
$3.22
N/A
P/E Ratio
★ $22.84
$33.27
Revenue Growth
★ N/A
N/A
52 Week Low
$26.49
$7.73
52 Week High
$43.13
$11.80

Technical Indicators

Market Signals
Indicator
BSRR
PRTA
Relative Strength Index (RSI) 36.22 44.91
Support Level $38.76 $8.12
Resistance Level $39.00 $9.29
Average True Range (ATR) 0.69 0.38
MACD -0.14 -0.02
Stochastic Oscillator 10.42 41.50

Price Performance

Historical Comparison
BSRR
PRTA

About BSRR Sierra Bancorp

Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. It offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.

Share on Social Networks: